EMEA-000237-PIP01-08-M10

Key facts

Invented name
Edarbi
Active substance
Azilsartan medoxomil
Therapeutic area
Cardiovascular diseases
Decision number
P/0530/2021
PIP number
EMEA-000237-PIP01-08-M10
Pharmaceutical form(s)
  • Tablet
  • Granules for oral suspension
Condition(s) / indication(s)
Treatment of hypertension
Route(s) of administration
Oral use
Contact for public enquiries
Takeda Development Centre Europe Ltd

Email: Pediatrics@tgrd.com
Tel. + (0)20331168000

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating
Average
1 rating
1 rating
1 rating